Fosamax

DRUG5 trials

Sponsors

University of California, San Francisco, Department of Clinical Research and Innovation, University of Rochester, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Yonsei University

Conditions

Cerebral PalsyDifferentiated Thyroid CancerOsteoporosisPerimenopausal Bone LossSpinal Cord Injury

Phase 3

Use of Oral Bisphosphonates in the Treatment of Osteoporosis of Non-walking Children With Cerebral Palsy

TerminatedNCT00822029

Department of Clinical Research and InnovationCerebral Palsy, Osteoporosis

Start: 2009-02-28End: 2011-02-28Updated: 2012-03-26

Phase 4

Phase IV Clinical Trial to Evaluate Efficacy and Safety of MASI BONE S (Alendronate Sodium Trihydrate) in Postmenopausal Women With Osteoporosis

Yonsei UniversityOsteoporosis

Start: 2021-07-02End: 2023-05-31Target: 170Updated: 2022-05-31

Unknown Phase

Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss

CompletedNCT00221312

University of California, San FranciscoPerimenopausal Bone Loss

Start: 2002-05-31End: 2007-07-31Updated: 2008-05-08

Pilot Study of Fosamax in Spinal Cord Injury

TerminatedNCT01131884

University of RochesterOsteoporosis, Spinal Cord Injury

Start: 2010-06-30End: 2012-12-31Updated: 2016-01-29

99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis

CompletedNCT02304757

Xinhua Hospital, Shanghai Jiao Tong University School of MedicineDifferentiated Thyroid Cancer, Osteoporosis

Start: 2015-01-31End: 2019-12-30Updated: 2021-11-17

Related Papers

Efficacy and safety of weekly liquid alendronate in Korean postmenopausal women with osteoporosis: a 12-month, multi-center, randomized trial

Archives of Osteoporosis2024-11-261 citations

<sup>99</sup>Tc-Methylene Diphosphonate Treatment is Safe and Efficacious for Osteoporosis in Postmenopausal Differentiated Thyroid Cancer Patients Undergoing TSH Suppression: A Three-Center Non-Randomized Clinical Study.

2022-03-054 citations